Associate Director, Oncology Field Reimbursement

This role is field-based, and candidates should live within a reasonable distance from the primary city. Talent will be hired at a level commensurate with experience.

Candidates may live in the following cities:

• Chicago, IL
• Dallas, TX

Purpose Statement:

The Associate Director, Oncology Field Reimbursement leads a regional team of Field Reimbursement Managers (FRMs) providing compliant access, reimbursement, and affordability support across the oncology portfolio. This leader is accountable for building, hiring, onboarding, coaching, and developing a high-performing FRM team that can execute across today’s portfolio while scaling for future launch needs. The role translates portfolio access strategy into disciplined field execution and partners cross-functionally with Patient Services, Market Access, Sales, Brand, Training, Analytics, Operations, Legal, Regulatory, Compliance, hub, and vendor partners.

Responsibilities

• Lead, coach, develop, and manage a regional Oncology FRM team.
• Build, hire, and onboard a portfolio-ready team with clear role expectations, territory readiness, development plans, and a culture of accountability, teamwork, compliance, customer focus, and high performance.
• Set and reinforce expectations for field execution, customer engagement, account prioritization, business planning, performance management, and compliant use of approved resources.
• Coach FRMs through field travel, ride-alongs, team meetings, business reviews, and individualized development plans.
• Ensure FRMs educate appropriate HCP office staff and account stakeholders on coverage, coding, billing, reimbursement, benefit verification, prior authorization, appeals, payer requirements, product acquisition, specialty pharmacy/distribution, and affordability support.
• Translate oncology portfolio strategy, franchise priorities, payer dynamics, patient support objectives, and multiple myeloma launch readiness into regional execution plans.
• Partner cross-functionally to define training, tools, workflows, dashboards, account education priorities, and feedback loops for portfolio and launch readiness.
• Monitor team activity, capacity, account coverage, quality, compliance, and performance through analytics, reporting tools, field insights, and business reviews.
• Engage key oncology and hematology accounts, when appropriate, to understand access barriers and support resolution of complex reimbursement or affordability challenges.
• Capture and escalate field insights related to payer policies, coverage barriers, prior authorization trends, site-of-care issues, coding/billing challenges, specialty distribution dynamics, customer education needs, and portfolio or launch risks.
• Contribute to the evolution of the Oncology FRM operating model, including recommendations for structure, workload balance, engagement cadence, performance measures, and field capability development.
• Ensure all activities comply with AbbVie policies, applicable laws and regulations, compliance requirements, and approved materials and processes.

Portfolio, Launch, and Team-Building Focus

• Build a portfolio-ready team with the capabilities and customer focus needed to support current oncology brands and future launch demands.
• Accelerate onboarding for new FRMs across role readiness, technical knowledge, territory understanding, portfolio fluency, and compliance expectations.
• Integrate current and new FRMs into one cohesive team with shared standards, trust, teamwork, and ownership of portfolio and launch outcomes.
• Establish field execution expectations across steady-state portfolio support, pre-launch readiness, launch, and post-launch execution.
• Use field insights to inform portfolio planning, multiple myeloma launch readiness, training, operational readiness, customer support needs, and continuous improvement.